Newsletter | February 23, 2023

02.23.23 -- EMA's Revised GMP Annex 1 Addresses Common Global Challenges For Sterile Products

Featured Editorial
Industry Insights
Ergonomic Biologic Injection Solutions For Targeted User Populations

Self-injection delivery formats are evolving beyond the 1 mL barrier to meet the emerging needs of biologic drug formulations while simultaneously serving patients by maintaining safety and ease of use. Injection volumes that are > 1 mL can be feasible for patients to inject manually provided that the delivery system design is easy to use, intuitive, and comfortable to hold and inject.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.